What British Minister Of Health Has To Say About The End Of AstraZeneca Vaccine Clinical Trial
What British Minister Of Health Has To Say About The End Of AstraZeneca Vaccine Clinical Trial
The British Minister of
Health affirmed that the decision to suspend the AstraZenec vaccine trial is a
step to ensure the correct process, whenever an incident occurs, it is
necessary to investigate and clarify.
UK Health Minister Matt
Hancock has quickly defended AstraZeneca's decision to suspend phase 3 clinical
trials on the vaccine sample developed by the company in cooperation with the
University of Oxford for safety reasons.
Specifically, speaking on
Sky News on 9/9, Mr. Hancock said that the fact that a volunteer participating
in clinical trials suspected of having side effects is a challenge for the
AstraZeneca vaccine sample.
However, Mr. Matt Hancock
confirmed, this is not the first incident with this vaccine. The decision
to suspend the test is a step to ensure the correct process, whenever there is
a problem, it is necessary to investigate and clarify.
When asked about the impact
of the event on potential vaccine development, Hancock said:
“It is not necessary to see this as a setback. It all depends on what the experts find out in the investigation.”
Earlier, on September 8,
AstraZeneca announced that it would suspend the COVID-19 vaccine trial study
called AZD1222, after a volunteer participating in a clinical trial showed
signs of an unexplained illness.
No comments